See All Slides - tctmd.com

Slides

Presentation TCT 2012

TCT-77. Initial and Mid-Term Angiographic Outcomes of Septal Channel Perforation Related to Retrograde Recanalization for Chronic Total Occlusions

Presenter: Hiroyuki Tanaka

October 23, 2012

Presentation TCT 2012

Long-term Results from PROTECT AF: Is the Risk-Benefit Ratio Really Uncertain?

Presenter: David Holmes Jr

October 23, 2012

Presentation TCT 2012

Preclinical Review: Perirenal Nerve Distribution, Density, and Quantification: Implications for the Evaluation of Device Safety and Efficacy

Presenter: Renu Virmani

October 23, 2012

Presentation TCT 2012

Statement: Molecular Imaging Will Transform the Evaluation of Atherosclerosis

Presenter: Farouc Jaffer

October 23, 2012

Presentation TCT 2012

TCT-48. Two Year Follow-up and Sub-group Analysis of a Polymer-free Sirolimus- and Probucol-eluting Stent vs. A New Generation Zotarolimus-eluting Stent in Coronary Artery Disease

Presenter: Lamin King

October 23, 2012

Presentation TCT 2012

Introduction(7)

Presenter: Jeffrey Kuvin

October 23, 2012

Presentation TCT 2012

Emotional Intelligence and Crucial Conversations

Presenter: Jennifer Tremmel

October 23, 2012

Presentation TCT 2012

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Presenter: Markus Schlaich

October 23, 2012

Presentation TCT 2012

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

Presenter: Roxana Mehran

October 23, 2012

Presentation TCT 2012

Contracts 101

Presenter: Thomas Tu

October 23, 2012

Advertisement

Slides

TCT-77. Initial and Mid-Term Angiographic Outcomes of Septal Channel Perforation Related to Retrograde Recanalization for Chronic Total Occlusions

Long-term Results from PROTECT AF: Is the Risk-Benefit Ratio Really Uncertain?

Preclinical Review: Perirenal Nerve Distribution, Density, and Quantification: Implications for the Evaluation of Device Safety and Efficacy

Statement: Molecular Imaging Will Transform the Evaluation of Atherosclerosis

TCT-48. Two Year Follow-up and Sub-group Analysis of a Polymer-free Sirolimus- and Probucol-eluting Stent vs. A New Generation Zotarolimus-eluting Stent in Coronary Artery Disease

Introduction(7)

Emotional Intelligence and Crucial Conversations

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

Contracts 101

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content